查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球心臟帮浦设备市场 2023-2030
市场调查报告书
商品编码
1380454

全球心臟帮浦设备市场 2023-2030

Global Heart Pump Device Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 205 Pages | 商品交期: 2-3个工作天内

价格

全球心臟帮浦设备市场预计在预测期内（2023-2030年）CAGR为21.4%。患有心血管疾病（CVD）的人数不断增加、心臟衰竭发病率上升等关键因素正在推动市场成长。据世界卫生组织称，心血管疾病 (CVD) 是全球主要死亡原因，每年估计夺走 1,790 万人的生命。此外，心臟泵产品研发投资的增加预计将透过促进这些设备的接受度和使用率的提高来推动市场成长。 2022 年 10 月，开发全人工心臟的临床前医疗器材公司 BiVACOR (R) 透过其医学研究未来基金 (MRFF) 和定向转化研究加速器 (TTRA) 计画获得了澳洲政府提供的 75 万美元资助。

细分市场前景

全球心臟帮浦设备市场按类型和最终用户进行细分。根据类型，市场分为植入式心臟帮浦设备和体外心臟帮浦设备。根据产品，市场细分为心室辅助装置、主动脉内球囊帮浦（IABP）和体外膜氧合（ECMO）。此外，根据最终用户，市场分为医院和心臟中心。在最终用户中，由于设备齐全、交通便利、信任和可靠，预计医院细分市场将占据相当大的市场份额。

预计心室辅助设备细分市场将在全球心泵设备市场中占据相当大的份额

其中，心室辅助装置细分市场预计将在全球心泵装置市场中占据相当大的份额。节段性增长归因于暂时性心臟衰竭发生率的上升，在等待捐赠心臟可用时暂时使用 LVAD，以及由于年龄或其他因素而无法进行心臟移植的人越来越多地使用 LVAD。此外，FDA 核准的产品数量不断增加也促进了 LVAD 的采用。 2019 年10 月，医疗技术先驱美敦力公司(Medtronic plc) 的用于晚期心臟衰竭患者的美敦力完全植入式LVAD 获得了美国食品和药物管理局(FDA) 的突破性设备认定，目前该产品正在开发中。

区域展望

全球心臟帮浦设备市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，亚太地区预计将在全球市场中占据显着份额，因为心臟衰竭盛行率的增加，以及新兴经济体可支配收入增加导致的生活方式的改变，正在推动亚太地区的心臟帮浦设备市场。

北美地区全球心泵设备市场预计将以显着的复合CAGR成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。推动北美市场的主要因素包括由于心血管疾病（CVD）和心臟衰竭而导致的心臟移植需求的增加。根据《2022 年心臟病和中风统计》，2019 年，CVD 被列为根本死因，美国有 874,613 人死亡。 2019年，美国大约每40秒就有一人罹患心肌梗塞，平均每3分30秒就有一人死于中风。然而，由于无法提供足够的心臟用于移植以满足现有需求，导致了短缺危机。此外，根据美国卫生资源与服务管理局 (HRSA) 的数据，截至 2023 年 9 月，心臟移植等候名单上有 3,292 名候选人。因此，心臟泵设备预计在未来几年将出现巨大的利用率和需求。

市场参与者展望

服务全球心臟帮浦设备市场的主要公司包括： Abbott Laboratories、Berlin Heart GmbH、Boston Scientific Corp.、Medtronic plc、Terumo Corp. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 11 月，强生公司与突破性心、肺和肾臟支持技术的全球供应商 Abiomed 签订了一项最终协议，根据该协议，强生公司透过要约收购收购了 Abiomed 的所有已发行股票，每股预付款380.0 美元现金，相当于企业价值约166 亿美元（其中包括收购的现金）。此次收购增加了心臟恢復解决方案，以补充其 Biosense Webster 电生理学业务，使该公司能够在高成长市场中扩张。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球心臟泵设备市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。
  • 透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Berlin Heart GmbH
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Boston Scientific Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球心臟帮浦设备市场
    • 植入式心臟帮浦装置
    • 体外心臟帮浦装置
  • 按产品分類的全球心泵设备市场
    • 心室辅助装置
      • 左心室辅助装置 (LVAD)
      • 右心室辅助装置 (RVAD)
      • 双心室辅助装置 (BiVAD)
      • 经皮心室辅助装置 (PVAD)
    • 全人工心臟 (TAH)
    • 体外膜氧合（ECMO）
  • 按最终用途分類的全球心泵设备市场
    • 医院
    • 心臟中心

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • BiVACOR Inc.
  • CardiacAssist, Inc. (TandemLife)
  • CARMAT
  • CorWave SA
  • Evaheart, Inc.
  • Fresenius SE & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Johnson & Johnson Services, Inc.
  • Leviticus-Cardio Ltd.
  • LivaNova PLC
  • ReliantHeart Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corp.
Product Code: OMR2027761

Title: Global Heart Pump Device Market Size, Share & Trends Analysis Report by Type (Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices), by Product (Ventricular Assist Devices, Total Artificial Hearts (TAHs), and Extracorporeal Membrane Oxygenation (ECMO)), and by End-User (Hospital and Cardiac Centers)Forecast Period (2023-2030).

The global heart pump device market is anticipated to grow at a CAGR of 21.4% during the Forecast Period (2023-2030). Pivotal factors including the increasing number of individuals suffering from cardiovascular diseases (CVD), rising incidences of heart failure are driving the market growth. According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Further, the increasing investment in R&D for heart pump products is projected to drive market growth by promoting increased acceptance and usage of these devices. In October 2022, BiVACOR®, a preclinical medical device company developing a Total Artificial Heart, received a $750k grant from the Australian Government through its medical research future fund (MRFF) and targeted translation research accelerator (TTRA) program.

Segmental Outlook

The global heart pump device market is segmented on the type, and end user. Based on the type, the market is sub-segmented into implanted heart pump devices and extracorporeal heart pump devices. Based on the product, the market is sub-segmented into ventricular assist devices, intra-aortic balloon pumps (IABPs) and extracorporeal membrane oxygenation (ECMO). Further, on the basis of end user, the market is sub-segmented into hospital and cardiac centers. Among the end user, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the well-equipped settings, easily accessible, trust and reliability.

The Ventricular Assist Devices Sub-Segment is Anticipated to Hold a Considerable Share of the Global Heart Pump Device Market

Among the product, the ventricular assist devices sub-segment is expected to hold a considerable share of the global heart pump device market. The segmental growth is attributed to the rising incidences of temporary heart failure, temporarily used of LVAD while waiting for a donor heart to become available, increasing use of LVAD who can't have a heart transplant because of age or other factors. Additionally, the rising number of FDA approvals of the products are also contributing to the increasing adoption for LVAD. In October 2019, Medtronic plc, the pioneer in medical technology, received breakthrough device designation from the US Food and Drug Administration (FDA) for the Medtronic Fully Implantable LVAD for patients with advanced heart failure, currently in development.

Regional Outlook

The global heart pump device market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of heart failure, and the and changes in lifestyles owing to rising disposable income in emerging economies are driving the heart pump device market in the Asia Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Heart Pump Device Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The major factors driving the North America market includes the increasing demand for heart transplantation owing to the Cardiovascular diseases' (CVDs) and heart failure. According to the Heart Disease and Stroke Statistics 2022, in 2019, CVD listed as the underlying cause of death, accounted for 874,613 mortalities in the US. In 2019, approximately every 40 seconds, one person in the US suffered with a myocardial infarction and on average people died of stroke every 3 minutes 30 seconds in the country. Though, the unavailability of adequate hearts for transplantation to meet the existing demand resulted in shortage crisis. Furtermore, according to the Health Resources and Services Administration (HRSA) US, as of September 2023, there were 3,292 candidates on heart transplant waiting list. Thus, the heart pump device is expected to witness a huge utilization and demand in the coming years.

Market Players Outlook

The major companies serving the global heart pump device market include: Abbott Laboratories, Berlin Heart GmbH, Boston Scientific Corp., Medtronic plc, Terumo Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Johnson & Johnson Inc. and Abiomed, a global provider in breakthrough heart, lung, and kidney support technologies, entered into a definitive agreement under which Johnson & Johnson acquired through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.0 per share in cash, corresponding to an enterprise value of approximately $16.6 billion which includes cash acquired. The acquisition added heart recovery solutions to complement its Biosense Webster electrophysiology business, allowing the company expand in high-growth markets.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global heart pump device market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight and Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Berlin Heart GmbH
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Boston Scientific Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Medtronic plc
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Heart Pump Device Market by Type
    • 4.1.1. Implanted Heart Pump Devices
    • 4.1.2. Extracorporeal Heart Pump Devices
  • 4.2. Global Heart Pump Device Market by Product
    • 4.2.1. Ventricular Assist Devices
      • 4.2.1.1. Left Ventricular Assist Devices (LVAD)
      • 4.2.1.2. Right Ventricular Assist Devices (RVAD)
      • 4.2.1.3. Bi-Ventricular Assist Devices (BiVAD)
      • 4.2.1.4. Percutaneous Ventricular Assist Devices (PVAD)
    • 4.2.2. Total Artificial Hearts (TAHs)
    • 4.2.3. Extracorporeal Membrane Oxygenation (ECMO)
  • 4.3. Global Heart Pump Device Market by End-Use
    • 4.3.1. Hospital
    • 4.3.2. Cardiac Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. BiVACOR Inc.
  • 6.2. CardiacAssist, Inc. (TandemLife)
  • 6.3. CARMAT
  • 6.4. CorWave SA
  • 6.5. Evaheart, Inc.
  • 6.6. Fresenius SE & Co. KGaA
  • 6.7. Getinge AB
  • 6.8. Jarvik Heart, Inc.
  • 6.9. Johnson & Johnson Services, Inc.
  • 6.10. Leviticus-Cardio Ltd.
  • 6.11. LivaNova PLC
  • 6.12. ReliantHeart Inc.
  • 6.13. SynCardia Systems, LLC
  • 6.14. Teleflex Incorporated
  • 6.15. Terumo Corp.

LIST OF TABLES

  • 1. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL IMPLANTED HEART PUMP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL EXTRACORPOREAL HEART PUMP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 5. GLOBAL VENTRICULAR ASSIST HEART PUMP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL TOTAL ARTIFICIAL HEARTS (TAHS) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INTRA-AORTIC BALLOON HEART PUMPS (IABPS) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) HEART PUMP MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY VENTRICULAR ASSIST DEVICES, 2022-2030 ($ MILLION)
  • 10. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL BI-VENTRICULAR ASSIST DEVICES (BIVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PERCUTANEOUS VENTRICULAR ASSIST DEVICES (PVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 15. GLOBAL HEART PUMP DEVICE FOR HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL HEART PUMP DEVICE FOR CARDIAC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 25. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 28. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HEART PUMP DEVICE MARKET SHARE BY COMPONENT, 2022 VS 2030 (%)
  • 2. GLOBAL IMPLANTED HEART PUMP DEVICE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL EXTRACORPOREAL HEART PUMP DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL HEART PUMP DEVICE MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 5. GLOBAL VENTRICULAR ASSIST HEART PUMP DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL VENTRICULAR ASSIST HEART PUMP DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL TOTAL ARTIFICIAL HEARTS (TAHS) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL INTRA-AORTIC BALLOON HEART PUMPS (IABPS) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) HEART PUMP MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL HEART PUMP DEVICE MARKET SHARE BY VENTRICULAR ASSIST DEVICES, 2022 VS 2030 (%)
  • 11. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL BI-VENTRICULAR ASSIST DEVICES (BIVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL PERCUTANEOUS VENTRICULAR ASSIST DEVICES (PVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL HEART PUMP DEVICE MARKET SHARE BY END-USE, 2022 VS 2030 (%)
  • 16. GLOBAL HEART PUMP DEVICE FOR HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL HEART PUMP DEVICE FOR CARDIAC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL HEART PUMP DEVICE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. US HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CANADA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. UK HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. FRANCE HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. GERMANY HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. ITALY HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SPAIN HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF EUROPE HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. INDIA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. CHINA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. JAPAN HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. SOUTH KOREA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)